Search research articles
Contact Us
Filters
Showing results (1-10 of 133) with videos related to
Page
of 14
Sort By:
Leukemia Research
|
November 22, 2002
Receptor upregulation enhances cell surface receptor targeted therapies
Arthur E Frankel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2002
New HER2-directed therapies for breast cancer. Commentary re: C. I. Spiridon et al., Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity. Clin. Cancer Res., 8: 1720-1730, 2002
Arthur E Frankel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Increased sophistication of immunotoxins
Arthur E Frankel
Clinical Pharmacology : Advances and Applications
|
December 20, 2013
Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunity
Arthur E Frankel
Leukemia Research
|
January 22, 2005
New anti-T cell immunotoxins for the clinic
Arthur E Frankel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2004
Reducing the immune response to immunotoxin
Arthur E Frankel
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 19, 2019
Autoimmune Bell's Palsy Following Immunotherapy For Metastatic Melanoma: A Report of 2 Cases
Daniel Zieman, Arthur E Frankel
Molecular Cancer Therapeutics
|
March 1, 2006
Apoptosis and anthracycline cardiotoxicity
Andrew Thorburn, Arthur E Frankel
Biomedicines
|
January 10, 2019
Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies
Omar Alkharabsheh, Arthur E Frankel
Leukemia Research
|
May 26, 2004
VEGF and myeloid leukemias
Arthur E Frankel, Parkash S Gill
Page
of 14
Search research articles
Search
Showing results (1-10 of 133) with videos related to
Sort By:
Page
of 14
Leukemia Research
|
November 22, 2002
Receptor upregulation enhances cell surface receptor targeted therapies
Arthur E Frankel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 13, 2002
New HER2-directed therapies for breast cancer. Commentary re: C. I. Spiridon et al., Targeting multiple Her-2 epitopes with monoclonal antibodies results in improved antigrowth activity. Clin. Cancer Res., 8: 1720-1730, 2002
Arthur E Frankel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 12, 2002
Increased sophistication of immunotoxins
Arthur E Frankel
Clinical Pharmacology : Advances and Applications
|
December 20, 2013
Special issue of clinical pharmacology: advances and applications in new protein therapeutics modulating tumor immunity
Arthur E Frankel
Leukemia Research
|
January 22, 2005
New anti-T cell immunotoxins for the clinic
Arthur E Frankel
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 22, 2004
Reducing the immune response to immunotoxin
Arthur E Frankel
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
July 19, 2019
Autoimmune Bell's Palsy Following Immunotherapy For Metastatic Melanoma: A Report of 2 Cases
Daniel Zieman, Arthur E Frankel
Molecular Cancer Therapeutics
|
March 1, 2006
Apoptosis and anthracycline cardiotoxicity
Andrew Thorburn, Arthur E Frankel
Biomedicines
|
January 10, 2019
Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies
Omar Alkharabsheh, Arthur E Frankel
Leukemia Research
|
May 26, 2004
VEGF and myeloid leukemias
Arthur E Frankel, Parkash S Gill
Page
of 14